IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against DaVita Inc. (“DaVita” or the “Company”) (Nasdaq: DVA) concerning possible violations of federal securities laws
If you purchased shares of DaVita Inc., and want more information free of charge, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
On January 6, 2017, the Wall Street Journal announced DaVita had received subpoenas from federal prosecutors for "the production of information related to charitable premium assistance" concerning the Company’s relationship with the American Kidney Fund, a charity that offers financial help for patients undergoing kidney dialysis. When this information was released to the public, the value of DaVita stock fell, causing investors severe harm.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some jurisdictions.